Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade.
Dong-Chun HongJing YangCong SunYuan-Tao LiuLu-Jun ShenBu-Shu XuYi QueXiaojun XiaXing ZhangPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elevated genomic instability and higher immune cell infiltrations was found in RISs than primary sarcomas. Moreover, higher efficacy of chemotherapy plus PD-1 blockade was observed in animal experiment and clinical practice. These evidence indicated the promising application of immune checkpoint inhibitors in the treatment of RISs.